FilingSEC EDGAR8-K
Outlook Therapeutics Receives Nasdaq Deficiency Notice for Minimum Bid Price
· SEC accepted
StageListing Maintenance
Filing content
The company received a notice from Nasdaq for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days, with a compliance deadline set for March 24, 2027.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…